Journal
ADVANCED DRUG DELIVERY REVIEWS
Volume 62, Issue 12, Pages 1141-1148Publisher
ELSEVIER
DOI: 10.1016/j.addr.2010.06.001
Keywords
Cell-derived vesicles; Stem cell plasticity; Epigenetic alteration; Cellular injury; Disease biomarker; Tissue restoration
Categories
Funding
- National Institutes of Health [5K08HL086868-03, 1P20 RR025179-01]
Ask authors/readers for more resources
Cell phenotype alteration by cell-derived vesicles presents a new aspect for consideration of cell fate. Accumulating data indicates that vesicles from many cells interact with or enter different target cells from other tissues, altering their phenotype toward that of the cell releasing the vesicles. Cells may be changed by direct interactions, transfer of cell surface receptors or epigenetic reprogramming via transcriptional regulators. Induced epigenetic changes appear to be stable and result in significant functional effects. These data force a reconsideration of the cellular context in which transcription regulates the proliferative and differentiative fate of tissues and suggests a highly plastic cellular system, which might underlay a relatively stable tissue system. The capacity of marrow to convert to non-hematopoietic cells related to vesicle cross-communication may underlie the phenomena of stem cell plasticity. Additionally, vesicles have promise in the clinical arenas of disease biomarkers, tissue restoration and control of neoplastic cell growth. (c) 2010 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available